Department of Physiology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Am J Hypertens. 2013 Sep;26(9):1123-31. doi: 10.1093/ajh/hpt082. Epub 2013 Jun 11.
The mechanisms by which heme oxygenase (HO) improves glucose metabolism in essential hypertension are not completely understood. Because dysfunctional insulin signaling is associated with elevated inflammation and high cholesterol and triglycerides, we investigated the effects of HO on the proinflammatory macrophage M1 phenotype and the anti-inflammatory macrophage M2 phenotype in spontaneously hypertensive rats (SHRs). SHRs are a model of human essential hypertension with features of metabolic syndrome, including impaired glucose metabolism.
Spectrophotometric analysis, enzyme immunoassay, enzyme-linked immunosorbent assay, and Western immunoblotting were used. HO was enhanced with hemin or inhibited with chromium-mesoporphyrin (CrMP).
Hemin suppressed inflammation by abating proinflammatory macro phage M1 phenotype (ED1) and chemokines such as macrophage chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein 1 alpha (MIP-1α) while enhancing anti-inflammatory macrophage M2 phenotype by potentiating ED2, CD206, and CD14. Similarly, hemin improved insulin signaling by enhancing insulin receptor substrate 1 (IRS-1), IRS-2, phosphatidylinositol 3 kinase (PI3K), and glucose transporter 4 (GLUT4) but reduced total cholesterol and triglycerides. These effects were accompanied by increased HO-1, HO activity, and cyclic guanosine monophosphate (cGMP), whereas the HO inhibitor CrMP nullified the hemin effects. Importantly, the effects of the HO system on ED1, ED2, CD206, and CD14 in SHRs are novel.
Hemin abated inflammation in SHRs by selectively enhancing the anti-inflammatory macrophage M2 phenotype that dampens inflammation while suppressing the pronflammatory macrophage M1 phenotype and related chemokines such as MCP-1 and MIP-1α. Importantly, the reduction of inflammation, total cholesterol, and triglycerides was accompanied by the enhancement of important proteins implicated in insulin signaling, including IRS-1, IRS-2, PI3K, and GLUT4. Thus, the concomitant reduction of inflammation, total cholesterol and triglycerides and the corresponding potentiation of insulin signaling are among the multifaceted mechanisms by which the HO system improves glucose metabolism in essential hypertension.
血红素加氧酶(HO)改善原发性高血压患者葡萄糖代谢的机制尚不完全清楚。由于功能失调的胰岛素信号与炎症升高、高胆固醇和甘油三酯有关,我们研究了 HO 对自发性高血压大鼠(SHR)中促炎巨噬细胞 M1 表型和抗炎巨噬细胞 M2 表型的影响。SHR 是一种具有代谢综合征特征的人类原发性高血压模型,包括葡萄糖代谢受损。
采用分光光度分析、酶免疫测定、酶联免疫吸附测定和 Western 免疫印迹法。用血红素增强 HO,用铬-中卟啉(CrMP)抑制 HO。
血红素通过减弱促炎巨噬细胞 M1 表型(ED1)和趋化因子如巨噬细胞趋化因子 1(MCP-1)和巨噬细胞炎性蛋白 1α(MIP-1α)来抑制炎症,同时通过增强 ED2、CD206 和 CD14 来增强抗炎巨噬细胞 M2 表型。同样,血红素通过增强胰岛素受体底物 1(IRS-1)、IRS-2、磷酸肌醇 3 激酶(PI3K)和葡萄糖转运蛋白 4(GLUT4)来改善胰岛素信号,但降低总胆固醇和甘油三酯。这些作用伴随着 HO-1、HO 活性和环鸟苷酸(cGMP)的增加,而 HO 抑制剂 CrMP 使血红素的作用无效。重要的是,HO 系统对 SHRs 中 ED1、ED2、CD206 和 CD14 的作用是新颖的。
血红素通过选择性增强抗炎巨噬细胞 M2 表型来减轻 SHRs 的炎症,从而抑制炎症,同时抑制促炎巨噬细胞 M1 表型和相关趋化因子如 MCP-1 和 MIP-1α。重要的是,炎症、总胆固醇和甘油三酯的减少伴随着参与胰岛素信号的重要蛋白的增强,包括 IRS-1、IRS-2、PI3K 和 GLUT4。因此,炎症、总胆固醇和甘油三酯的减少以及胰岛素信号的相应增强是 HO 系统改善原发性高血压患者葡萄糖代谢的多种机制之一。